EHC · Encompass Health Corporation Common Stock
View on chartInsiders & Stakes
| Mark J. Tarr President & CEO | ▼ Sell | Open Market | 267,814 Shares held | 8/10/2026 | View profile |
| John Chidsey Director | ▲ Buy | Grant | 162,826 Shares held | 4/16/2024 | View profile |
| Donald L. Correll Director | ▲ Buy | Grant | 99,938 Shares held | 4/15/2024 | View profile |
| SHAW L EDWARD JR Director | ▲ Buy | Grant | 99,385 Shares held | 4/19/2022 | View profile |
| Edmund Fay Sr. Vice Pres. and Treasurer | ▼ Sell | Gift | 86,325 Shares held | 3/9/2026 | View profile |
| ELSON CHARLES M Director | ▲ Buy | Grant | 82,981 Shares held | 4/18/2022 | View profile |
| MAUPIN JOHN E JR D D S Director | ▲ Buy | Grant | 81,262 Shares held | 4/19/2022 | View profile |
| CURL YVONNE M Director | ▲ Buy | Grant | 78,458 Shares held | 4/18/2022 | View profile |
| John Patrick Darby EVP, Gen Counsel & Secretary | ▼ Sell | Open Market | 75,041 Shares held | 8/31/2026 | View profile |
| Andrew L. Price Chief Accounting Officer | ▼ Sell | Open Market | 69,483 Shares held | 8/31/2026 | View profile |
| Jacobsmeyer Barbara Ann President & CEO, HHH | ▲ Buy | Grant | 59,539 Shares held | 2/25/2022 | View profile |
| Douglas E. Coltharp Director | ▼ Sell | Open Market | 50,508 Shares held | 8/10/2026 | View profile |
| Leslye G. Katz Director | ▲ Buy | Grant | 49,643 Shares held | 7/15/2026 | View profile |
| Joan E. Herman Director | ▲ Buy | Grant | 49,643 Shares held | 7/15/2026 | View profile |
| Patrick William Tuer EVP, Chief Operating Officer | ▼ Sell | Open Market | 24,755 Shares held | 5/11/2026 | View profile |
| Nancy M. Schlichting Director | ▲ Buy | Grant | 22,972 Shares held | 7/15/2026 | View profile |
| Greg D. Carmichael Director | ▲ Buy | Grant | 20,349 Shares held | 7/15/2026 | View profile |
| Christopher R. Reidy Director | ▲ Buy | Grant | 17,777 Shares held | 7/16/2026 | View profile |
| Elissa Joy Charbonneau Chief Medical Officer | ▼ Sell | Tax Withholding | 17,644 Shares held | 2/28/2026 | View profile |
| Terrance Williams Director | ▲ Buy | Grant | 16,859 Shares held | 7/15/2026 | View profile |
| Patricia Anne Maryland Director | ▲ Buy | Grant | 14,764 Shares held | 7/15/2025 | View profile |
| Kevin J. O'Connor Director | ▲ Buy | Grant | 11,582 Shares held | 7/15/2026 | View profile |
| Edward M. Christie III Director | ▲ Buy | Grant | 9,345 Shares held | 7/16/2026 | View profile |
| HIGDON LEO I JR Director | ▲ Buy | Grant | 5,104 Shares held | 4/18/2022 | View profile |
| Cain A. Hayes Director | ▲ Buy | Grant | 2,096 Shares held | 7/15/2026 | View profile |
| Encompass Health Corp 10% Owner | ▼ Sell | Other | 0 Shares held | 7/1/2022 | View profile |
Transaction History
| Andrew L. Price | ▼ Sell | Open Market | 5,211 | $630K | 8/31/2026 |
| John Patrick Darby | ▲ Buy | Option Exercise | 4,858 | $170K | 8/31/2026 |
| John Patrick Darby | ▼ Sell | Open Market | 4,858 | $588K | 8/31/2026 |
| Douglas E. Coltharp | ▼ Sell | Open Market | 18,869 | $2.4M | 8/10/2026 |
| Mark J. Tarr | ▼ Sell | Open Market | 171,569 | $21.5M | 8/10/2026 |
| Mark J. Tarr | ▼ Sell | Open Market | 1,579 | $199K | 8/10/2026 |
| John Patrick Darby | ▼ Sell | Open Market | 8,906 | $1.1M | 8/10/2026 |
| Christopher R. Reidy | ▲ Buy | Grant | 319 | $36K | 7/16/2026 |
| Edward M. Christie III | ▲ Buy | Grant | 248 | $28K | 7/16/2026 |
| Christopher R. Reidy | ▲ Buy | Grant | 21 | $0 | 7/15/2026 |
| Edward M. Christie III | ▲ Buy | Grant | 11 | $0 | 7/15/2026 |
| Terrance Williams | ▲ Buy | Grant | 29 | $0 | 7/15/2026 |
| Nancy M. Schlichting | ▲ Buy | Grant | 40 | $0 | 7/15/2026 |
| Kevin J. O'Connor | ▲ Buy | Grant | 19 | $0 | 7/15/2026 |
| Leslye G. Katz | ▲ Buy | Grant | 85 | $0 | 7/15/2026 |
| Joan E. Herman | ▲ Buy | Grant | 85 | $0 | 7/15/2026 |
| Cain A. Hayes | ▲ Buy | Grant | 4 | $0 | 7/15/2026 |
| Greg D. Carmichael | ▲ Buy | Grant | 29 | $0 | 7/15/2026 |
| Douglas E. Coltharp | ▲ Buy | Option Exercise | 27,694 | $912K | 5/15/2026 |
| Douglas E. Coltharp | ▼ Sell | Open Market | 27,693 | $3.0M | 5/15/2026 |
| Douglas E. Coltharp | ▼ Sell | Open Market | 1 | $107 | 5/15/2026 |
| Patrick William Tuer | ▼ Sell | Open Market | 682 | $71K | 5/11/2026 |
| Kevin J. O'Connor | ▲ Buy | Grant | 1,634 | $0 | 5/7/2026 |
| Edward M. Christie III | ▲ Buy | Grant | 1,634 | $0 | 5/7/2026 |
| Christopher R. Reidy | ▲ Buy | Grant | 1,634 | $0 | 5/7/2026 |
| Cain A. Hayes | ▲ Buy | Grant | 1,634 | $0 | 5/7/2026 |
| Greg D. Carmichael | ▲ Buy | Grant | 1,634 | $0 | 5/7/2026 |
| Terrance Williams | ▲ Buy | Grant | 1,634 | $0 | 5/7/2026 |
| Leslye G. Katz | ▲ Buy | Grant | 1,634 | $0 | 5/7/2026 |
| Joan E. Herman | ▲ Buy | Grant | 1,634 | $0 | 5/7/2026 |
| Nancy M. Schlichting | ▲ Buy | Grant | 1,634 | $0 | 5/7/2026 |
| Edward M. Christie III | ▲ Buy | Grant | 261 | $28K | 4/16/2026 |
| Christopher R. Reidy | ▲ Buy | Grant | 334 | $36K | 4/16/2026 |
| Greg D. Carmichael | ▲ Buy | Grant | 27 | $0 | 4/15/2026 |
| Edward M. Christie III | ▲ Buy | Grant | 9 | $0 | 4/15/2026 |
| Cain A. Hayes | ▲ Buy | Grant | 1 | $0 | 4/15/2026 |
| Joan E. Herman | ▲ Buy | Grant | 85 | $0 | 4/15/2026 |
| Leslye G. Katz | ▲ Buy | Grant | 85 | $0 | 4/15/2026 |
| Kevin J. O'Connor | ▲ Buy | Grant | 17 | $0 | 4/15/2026 |
| Christopher R. Reidy | ▲ Buy | Grant | 19 | $0 | 4/15/2026 |
| Nancy M. Schlichting | ▲ Buy | Grant | 39 | $0 | 4/15/2026 |
| Terrance Williams | ▲ Buy | Grant | 27 | $0 | 4/15/2026 |
| Edmund Fay | ▼ Sell | Open Market | 11,937 | $1.3M | 3/9/2026 |
| Edmund Fay | ▼ Sell | Gift | 3,000 | $0 | 3/9/2026 |
| Andrew L. Price | ▼ Sell | Tax Withholding | 307 | $33K | 2/28/2026 |
| Edmund Fay | ▼ Sell | Tax Withholding | 280 | $30K | 2/28/2026 |
| Elissa Joy Charbonneau | ▼ Sell | Tax Withholding | 369 | $40K | 2/28/2026 |
| John Patrick Darby | ▼ Sell | Tax Withholding | 416 | $45K | 2/28/2026 |
| Mark J. Tarr | ▼ Sell | Tax Withholding | 2,187 | $236K | 2/28/2026 |
| Patrick William Tuer | ▼ Sell | Tax Withholding | 545 | $59K | 2/28/2026 |
| Douglas E. Coltharp | ▼ Sell | Tax Withholding | 776 | $84K | 2/28/2026 |
| Mark J. Tarr | ▼ Sell | Tax Withholding | 2,488 | $264K | 2/23/2026 |
| Edmund Fay | ▼ Sell | Tax Withholding | 380 | $40K | 2/23/2026 |
| Patrick William Tuer | ▼ Sell | Tax Withholding | 506 | $54K | 2/23/2026 |
| Douglas E. Coltharp | ▼ Sell | Tax Withholding | 14,818 | $1.6M | 2/23/2026 |
| Andrew L. Price | ▼ Sell | Tax Withholding | 404 | $43K | 2/23/2026 |
| Elissa Joy Charbonneau | ▼ Sell | Tax Withholding | 440 | $47K | 2/23/2026 |
| John Patrick Darby | ▼ Sell | Tax Withholding | 6,990 | $742K | 2/23/2026 |
| Elissa Joy Charbonneau | ▼ Sell | Tax Withholding | 287 | $31K | 2/20/2026 |
| Mark J. Tarr | ▼ Sell | Tax Withholding | 1,797 | $191K | 2/20/2026 |
| Edmund Fay | ▼ Sell | Tax Withholding | 208 | $22K | 2/20/2026 |
| Andrew L. Price | ▼ Sell | Tax Withholding | 228 | $24K | 2/20/2026 |
| John Patrick Darby | ▼ Sell | Tax Withholding | 328 | $35K | 2/20/2026 |
| Douglas E. Coltharp | ▼ Sell | Tax Withholding | 674 | $72K | 2/20/2026 |
| Patrick William Tuer | ▼ Sell | Tax Withholding | 405 | $43K | 2/20/2026 |
| Douglas E. Coltharp | ▲ Buy | Grant | 4,430 | $0 | 2/19/2026 |
| Andrew L. Price | ▲ Buy | Grant | 1,560 | $0 | 2/19/2026 |
| Mark J. Tarr | ▲ Buy | Grant | 12,796 | $0 | 2/19/2026 |
| Edmund Fay | ▲ Buy | Grant | 1,430 | $0 | 2/19/2026 |
| Patrick William Tuer | ▲ Buy | Grant | 3,790 | $0 | 2/19/2026 |
| Elissa Joy Charbonneau | ▼ Sell | Tax Withholding | 4,016 | $430K | 2/19/2026 |
| Mark J. Tarr | ▼ Sell | Tax Withholding | 43,378 | $4.6M | 2/19/2026 |
| Edmund Fay | ▼ Sell | Tax Withholding | 3,479 | $373K | 2/19/2026 |
| Andrew L. Price | ▼ Sell | Tax Withholding | 3,692 | $396K | 2/19/2026 |
| John Patrick Darby | ▼ Sell | Tax Withholding | 7,903 | $847K | 2/19/2026 |
| Douglas E. Coltharp | ▼ Sell | Tax Withholding | 16,708 | $1.8M | 2/19/2026 |
| Patrick William Tuer | ▼ Sell | Tax Withholding | 3,193 | $342K | 2/19/2026 |
| Elissa Joy Charbonneau | ▲ Buy | Grant | 1,884 | $0 | 2/19/2026 |
| John Patrick Darby | ▲ Buy | Grant | 2,154 | $0 | 2/19/2026 |
| Douglas E. Coltharp | ▲ Buy | Grant | 37,588 | $0 | 2/18/2026 |
| Mark J. Tarr | ▲ Buy | Grant | 100,946 | $0 | 2/18/2026 |
| Edmund Fay | ▲ Buy | Grant | 7,690 | $0 | 2/18/2026 |
| Andrew L. Price | ▲ Buy | Grant | 8,178 | $0 | 2/18/2026 |
| Patrick William Tuer | ▲ Buy | Grant | 10,254 | $0 | 2/18/2026 |
| Elissa Joy Charbonneau | ▲ Buy | Grant | 8,914 | $0 | 2/18/2026 |
| John Patrick Darby | ▲ Buy | Grant | 17,720 | $0 | 2/18/2026 |
| Mark J. Tarr | ▼ Sell | Open Market | 16,216 | $1.8M | 2/11/2026 |
| Mark J. Tarr | ▼ Sell | Open Market | 13,231 | $1.4M | 2/11/2026 |
| Mark J. Tarr | ▼ Sell | Open Market | 15,584 | $1.7M | 2/11/2026 |
| Mark J. Tarr | ▼ Sell | Open Market | 10,954 | $1.2M | 2/11/2026 |
| Mark J. Tarr | ▼ Sell | Open Market | 6,057 | $678K | 2/11/2026 |
| Mark J. Tarr | ▼ Sell | Open Market | 87,745 | $9.9M | 2/11/2026 |
| Mark J. Tarr | ▼ Sell | Open Market | 213 | $24K | 2/11/2026 |
| Patrick William Tuer | ▼ Sell | Open Market | 2,804 | $302K | 2/10/2026 |
| Cain A. Hayes | ▲ Buy | Grant | 457 | $0 | 1/30/2026 |
| Leslye G. Katz | ▲ Buy | Grant | 87 | $0 | 1/15/2026 |
| Kevin J. O'Connor | ▲ Buy | Grant | 17 | $0 | 1/15/2026 |
| Nancy M. Schlichting | ▲ Buy | Grant | 40 | $0 | 1/15/2026 |
| Terrance Williams | ▲ Buy | Grant | 28 | $0 | 1/15/2026 |
| Edward M. Christie III | ▲ Buy | Grant | 9 | $0 | 1/15/2026 |
| Christopher R. Reidy | ▲ Buy | Grant | 19 | $0 | 1/15/2026 |
| Joan E. Herman | ▲ Buy | Grant | 87 | $0 | 1/15/2026 |
| Edward M. Christie III | ▲ Buy | Grant | 269 | $28K | 1/15/2026 |
| Christopher R. Reidy | ▲ Buy | Grant | 346 | $36K | 1/15/2026 |
| Greg D. Carmichael | ▲ Buy | Grant | 28 | $0 | 1/15/2026 |
| Greg D. Carmichael | ▲ Buy | Grant | 23 | $0 | 10/15/2025 |
| Edward M. Christie III | ▲ Buy | Grant | 7 | $0 | 10/15/2025 |
| Edward M. Christie III | ▲ Buy | Grant | 223 | $27K | 10/15/2025 |
| Leslye G. Katz | ▲ Buy | Grant | 73 | $0 | 10/15/2025 |
| Kevin J. O'Connor | ▲ Buy | Grant | 14 | $0 | 10/15/2025 |
| Christopher R. Reidy | ▲ Buy | Grant | 16 | $0 | 10/15/2025 |
| Terrance Williams | ▲ Buy | Grant | 23 | $0 | 10/15/2025 |
| Christopher R. Reidy | ▲ Buy | Grant | 288 | $35K | 10/15/2025 |
| Nancy M. Schlichting | ▲ Buy | Grant | 33 | $0 | 10/15/2025 |
| Joan E. Herman | ▲ Buy | Grant | 73 | $0 | 10/15/2025 |
| Patrick William Tuer | ▼ Sell | Open Market | 1,020 | $126K | 8/27/2025 |
| Douglas E. Coltharp | ▼ Sell | Gift | 27,480 | $0 | 8/21/2025 |
| Douglas E. Coltharp | ▼ Sell | Gift | 27,480 | $0 | 8/21/2025 |
| Christopher R. Reidy | ▲ Buy | Grant | 333 | $36K | 7/16/2025 |
| Edward M. Christie III | ▲ Buy | Grant | 260 | $28K | 7/16/2025 |
| Nancy M. Schlichting | ▲ Buy | Grant | 34 | $0 | 7/15/2025 |
| Kevin J. O'Connor | ▲ Buy | Grant | 15 | $0 | 7/15/2025 |
| Joan E. Herman | ▲ Buy | Grant | 74 | $0 | 7/15/2025 |
| Greg D. Carmichael | ▲ Buy | Grant | 24 | $0 | 7/15/2025 |
| Terrance Williams | ▲ Buy | Grant | 24 | $0 | 7/15/2025 |
| Patricia Anne Maryland | ▲ Buy | Grant | 24 | $0 | 7/15/2025 |
| Edward M. Christie III | ▲ Buy | Grant | 8 | $0 | 7/15/2025 |
| Christopher R. Reidy | ▲ Buy | Grant | 17 | $0 | 7/15/2025 |
| Leslye G. Katz | ▲ Buy | Grant | 74 | $0 | 7/15/2025 |
| Mark J. Tarr | ▲ Buy | Option Exercise | 56,306 | $2.0M | 5/20/2025 |
| Mark J. Tarr | ▲ Buy | Option Exercise | 62,078 | $2.8M | 5/20/2025 |
| Mark J. Tarr | ▼ Sell | Open Market | 94 | $11K | 5/20/2025 |
| Mark J. Tarr | ▼ Sell | Open Market | 118,290 | $14.4M | 5/20/2025 |
| Edmund Fay | ▼ Sell | Gift | 3,667 | $0 | 5/14/2025 |
| Elissa Joy Charbonneau | ▼ Sell | Open Market | 4,279 | $499K | 5/6/2025 |
| Greg D. Carmichael | ▲ Buy | Grant | 1,424 | $0 | 5/1/2025 |
| Edward M. Christie III | ▲ Buy | Grant | 1,424 | $0 | 5/1/2025 |
| Joan E. Herman | ▲ Buy | Grant | 1,424 | $0 | 5/1/2025 |
| Leslye G. Katz | ▲ Buy | Grant | 1,424 | $0 | 5/1/2025 |
| Patricia Anne Maryland | ▲ Buy | Grant | 1,424 | $0 | 5/1/2025 |
| Kevin J. O'Connor | ▲ Buy | Grant | 1,424 | $0 | 5/1/2025 |
| Christopher R. Reidy | ▲ Buy | Grant | 1,424 | $0 | 5/1/2025 |
| Nancy M. Schlichting | ▲ Buy | Grant | 1,424 | $0 | 5/1/2025 |
| Terrance Williams | ▲ Buy | Grant | 1,424 | $0 | 5/1/2025 |
| Patrick William Tuer | ▲ Buy | Grant | 5,984 | $0 | 4/30/2025 |
| Douglas E. Coltharp | ▼ Sell | Open Market | 26,239 | $3.0M | 4/29/2025 |
| Douglas E. Coltharp | ▼ Sell | Open Market | 13,402 | $1.5M | 4/29/2025 |
| Douglas E. Coltharp | ▼ Sell | Open Market | 3,934 | $458K | 4/29/2025 |
| John Patrick Darby | ▲ Buy | Option Exercise | 10,000 | $351K | 4/29/2025 |
| John Patrick Darby | ▼ Sell | Open Market | 10,000 | $1.1M | 4/29/2025 |
| Douglas E. Coltharp | ▲ Buy | Option Exercise | 16,075 | $467K | 4/29/2025 |
| Douglas E. Coltharp | ▲ Buy | Option Exercise | 27,500 | $906K | 4/29/2025 |
| Edward M. Christie III | ▲ Buy | Grant | 268 | $27K | 4/24/2025 |
| Christopher R. Reidy | ▲ Buy | Grant | 360 | $35K | 4/22/2025 |
| Patricia Anne Maryland | ▲ Buy | Grant | 23 | $0 | 4/15/2025 |
| Edward M. Christie III | ▲ Buy | Grant | 5 | $0 | 4/15/2025 |
| Leslye G. Katz | ▲ Buy | Grant | 76 | $0 | 4/15/2025 |
| Terrance Williams | ▲ Buy | Grant | 23 | $0 | 4/15/2025 |
| Christopher R. Reidy | ▲ Buy | Grant | 15 | $0 | 4/15/2025 |
| Joan E. Herman | ▲ Buy | Grant | 76 | $0 | 4/15/2025 |
| Kevin J. O'Connor | ▲ Buy | Grant | 13 | $0 | 4/15/2025 |
| Nancy M. Schlichting | ▲ Buy | Grant | 33 | $0 | 4/15/2025 |
| Greg D. Carmichael | ▲ Buy | Grant | 23 | $0 | 4/15/2025 |
| Mark J. Tarr | ▼ Sell | Tax Withholding | 2,187 | $219K | 2/28/2025 |
| Elissa Joy Charbonneau | ▼ Sell | Tax Withholding | 364 | $36K | 2/28/2025 |
| Douglas E. Coltharp | ▼ Sell | Tax Withholding | 776 | $78K | 2/28/2025 |
| John Patrick Darby | ▼ Sell | Tax Withholding | 416 | $42K | 2/28/2025 |
| Edmund Fay | ▼ Sell | Tax Withholding | 276 | $28K | 2/28/2025 |
| Andrew L. Price | ▼ Sell | Tax Withholding | 304 | $30K | 2/28/2025 |
| Elissa Joy Charbonneau | ▼ Sell | Tax Withholding | 506 | $51K | 2/25/2025 |
| John Patrick Darby | ▼ Sell | Tax Withholding | 509 | $51K | 2/25/2025 |
| Douglas E. Coltharp | ▼ Sell | Tax Withholding | 1,079 | $109K | 2/25/2025 |
| Edmund Fay | ▼ Sell | Tax Withholding | 384 | $39K | 2/25/2025 |
| Mark J. Tarr | ▼ Sell | Tax Withholding | 2,896 | $291K | 2/25/2025 |
| Andrew L. Price | ▼ Sell | Tax Withholding | 410 | $41K | 2/25/2025 |
| Elissa Joy Charbonneau | ▼ Sell | Tax Withholding | 435 | $42K | 2/24/2025 |
| John Patrick Darby | ▼ Sell | Tax Withholding | 437 | $43K | 2/24/2025 |
| Douglas E. Coltharp | ▼ Sell | Tax Withholding | 927 | $90K | 2/24/2025 |
| Edmund Fay | ▼ Sell | Tax Withholding | 374 | $36K | 2/24/2025 |
| Mark J. Tarr | ▼ Sell | Tax Withholding | 2,488 | $243K | 2/24/2025 |
| Andrew L. Price | ▼ Sell | Tax Withholding | 401 | $39K | 2/24/2025 |
| Douglas E. Coltharp | ▲ Buy | Grant | 4,557 | $0 | 2/20/2025 |
| Edmund Fay | ▲ Buy | Grant | 1,404 | $0 | 2/20/2025 |
| John Patrick Darby | ▲ Buy | Grant | 2,216 | $0 | 2/20/2025 |
| Elissa Joy Charbonneau | ▲ Buy | Grant | 1,939 | $0 | 2/20/2025 |
| Andrew L. Price | ▲ Buy | Grant | 1,538 | $0 | 2/20/2025 |
| Mark J. Tarr | ▲ Buy | Grant | 12,152 | $0 | 2/20/2025 |
| Andrew L. Price | ▼ Sell | Open Market | 5,042 | $496K | 2/13/2025 |
| Edward M. Christie III | ▲ Buy | Grant | 292 | $28K | 1/16/2025 |
| Christopher R. Reidy | ▲ Buy | Grant | 375 | $35K | 1/16/2025 |
| Greg D. Carmichael | ▲ Buy | Grant | 25 | $0 | 1/15/2025 |
| Edward M. Christie III | ▲ Buy | Grant | 6 | $0 | 1/15/2025 |
| Joan E. Herman | ▲ Buy | Grant | 83 | $0 | 1/15/2025 |
| Terrance Williams | ▲ Buy | Grant | 25 | $0 | 1/15/2025 |
| Nancy M. Schlichting | ▲ Buy | Grant | 36 | $0 | 1/15/2025 |
| Christopher R. Reidy | ▲ Buy | Grant | 16 | $0 | 1/15/2025 |
| Kevin J. O'Connor | ▲ Buy | Grant | 14 | $0 | 1/15/2025 |
| Patricia Anne Maryland | ▲ Buy | Grant | 25 | $0 | 1/15/2025 |
| Leslye G. Katz | ▲ Buy | Grant | 83 | $0 | 1/15/2025 |
| Elissa Joy Charbonneau | ▼ Sell | Tax Withholding | 2,991 | $276K | 1/1/2025 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Encompass Health Sets Q3 2026 Earnings Call Date
Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.
Encompass Health Sets Q3 2026 Earnings Call Date. Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.